About us
Synvero Health is a US health-tech company developing AI-powered digital adherence, monitoring and coaching solutions. They enable more efficient inhaled drug delivery and better clinical outcomes for patients with pulmonary diseases, including asthma and COPD.
What we do
01
Driven by proprietary AI and technology, our FDA-listed Kata app guides, monitors and coaches patients during inhalation. It helps them improve inhaler technique and reduce critical device-handling errors, which occur in up to 80% of inhalations and lead to inadequate drug delivery and poor disease control.
02
Kata is clinically proven and compatible with more than 95% of inhaler devices. It requires only a smartphone, enabling rapid deployment across health systems, and has the potential to set a new digital standard for inhaler technique training, adherence and monitoring.
03
Synvero is preparing for US market entry through commercial partnerships with payers, health networks and providers, initially targeting large asthma and COPD populations with significant unmet needs: more than 24 million US patients.
At a glance
A US health-tech company developing AI-driven digital health adherence solutions to coach and monitor inhaled therapies for asthma and COPD patients.
Poor inhaler technique is common and hard to fix. It leads to low drug delivery, poor disease control and costly care complications.
The Kata digital health app is clinically validated and FDA-listed as a medical device. Its AI and technology are protected by US, EU and Asian patents.
Compatible with more than 95% of inhaler devices and requiring only a smartphone, Kata can be deployed rapidly across health systems.
Market opportunity
$13.28B
US inhalable drug market, estimated value in 2021
6.1%
compound annual growth rate, 2023 to 2030
Growth is driven by:
Dry powder inhalers and aerosol-based therapies remain the dominant device types for inhalable therapies, today and in the future.
Source: Grand View Research, 2022.
Our team
CEO & Founder
30 years in US and international healthcare roles as commercial lead, with product launch and market access experience at Novartis, Gilead, Lundbeck, Vertex, Zambon-Breath Therapeutics and VisionHealth.
CTO & Founder
Medical engineer with 20 years of experience in the life science industry, including HealthTech, Digital Therapeutics, MedTech, and Pharma. Proven track record across leadership roles with a strong focus on development, innovation, and operational excellence.
CFO & Founder
25 years of experience in the life science industry, including VisionHealth. Has supported several biotech and medtech companies at different stages of maturity as CFO.
Founder & Strategic Advisor
Strategic advisor to senior decision-makers in the biopharmaceutical industry.
Work with us
We are preparing our US market entry through commercial partnership with payers, health networks and providers who treat patients with respiratory diseases. Health care professionals, payers and investors: we’d like to engage with you.
